Not Yet RecruitingNot Applicable

(Withdrawal) AI-Based Low-Dose 3D-DSA Reconstruction

China134 participantsStarted 2025-04-15

Plain-language summary

If the participants agree to participate in this study, the participants will undergo two scans (classic 3D-DSA and PS-3D-DSA assisted scan) to compare the imaging effects of both. After the procedure, the investigators will record the radiation exposure and collect DSA images.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Age ≥18 years.
✓. Requires 3D-DSA-guided interventional diagnosis or treatment (e.g., cerebral angiography, cerebral artery chemoembolization) and meets operational indications.
✓. Can understand the study's purpose, procedures, potential risks, and benefits, and voluntarily signs a written informed consent form.

Exclusion criteria

✕. Severe heart or lung disease, such as heart failure or chronic obstructive pulmonary disease (COPD).
✕. History of high-dose radiation exams or treatments.
✕. Known allergies or severe adverse reactions to iodine contrast agents or other relevant medications.
✕. Pregnant or breastfeeding women.
✕. Severe comorbidities or chronic diseases (e.g., severe diabetes, renal insufficiency).
✕. Severe mental illness or cognitive impairment preventing understanding of the study procedures or providing informed consent.

What they're measuring

The radiation dose received by patients during interventional procedures when using two scanning protocols (classic 3D-DSA and PS-3D-DSA)

Timeframe: No more than 6 hours

Trial details

NCT IDNCT06769867

SponsorUnion Hospital, Tongji Medical College, Huazhong University of Science and Technology

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-05-31

Contact for this trial

Huangxuan Zhao, PhD

+86 18627162379 zhao_huangxuan@sina.com

View on ClinicalTrials.gov More Cerebrovascular Disease trials